The FDA has notified healthcare professionals about syringe connection problems when certain needleless glass syringes containing adenosine and amiodarone are used with particular types of IV access ...

Antiarrhythmic drugs are used commonly in out-of-hospital cardiac arrest for shock-refractory ventricular fibrillation or pulseless ventricular tachycardia, but without proven survival benefit. In ...

The FDA has issued an alert to healthcare professionals regarding the use of two cardiac drugs, amiodarone and adenosine, in prefilled needleless glass syringes. This follows an increasing number of ...

The Food and Drug Administration is notifying health care professionals, especially those working in emergency and critical care settings, of reports of compatibility problems when certain needleless ...

Lidocaine has been the initial antiarrhythmic drug treatment recommended for patients with ventricular fibrillation that is resistant to conversion by defibrillator shocks. We performed a randomized ...

Sagent announced the reintroduction of Amiodarone HCl Injection, now in an improved prefilled plastic syringe that is compatible with most standard IV pumps. RELATED: Cardiovascular Disease Resource ...

What is amiodarone used for? Amiodarone is commonly used to prevent and treat certain types of serious (and sometimes life-threatening) arrhythmias called ventricular fibrillation and ventricular ...

SCHAUMBURG, Ill., July 25 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company, today announced that it haslaunched amiodarone HCl injection, USP, a class III antiarrhythmic ...

May 9, 2011 — Clinicians should avoid using needleless glass syringes prefilled with 2 cardiac drugs because of continued malfunctions that can delay administration during emergencies and result in ...